Home|Journals|Articles by Year|Audio Abstracts RSS - TOC

Original Article

J App Pharm Sci. 2017; 7(10): 162-167

A Prospective Observational Study on Polypharmacy in Geriatrics at A Private Corporate Hospital

Viswam K. Subeesh, Nair Gouri, Elsa Thomas Beulah, Velu Shivashankar.


Objective: To investigate the prevalence, different factors and consequences associated with polypharmacy in geriatrics.
Methodology: A prospective observational study was carried out for a duration of nine months in a private corporate hospital, Coimbatore, Tamil Nadu. Patients above 65 years were included in the study. The collected data was investigated for polypharmacy and analyzed for factors and consequences associated with polypharmacy.
Results: A total of 210 patients were included in the study. The average age of the study population was found to be 72.9 ± 6.5. An average hospital stay of the study population was found to be 10.22±8.7 days. A total of 2034 drugs were prescribed for the study population. The average number of drugs prescribed for the study population was found to be 9.68 (±1.94) with a minimum of 5 drugs to the maximum of 14 drugs during the study period, 110 (52%) among the study population were found to be prescribed with potentially inappropriate medications (PIMs). The mean value of drug related problems (DRP) in the study population was found to be 1.81±1.3. Conclusion: The prevalence of polypharmacy and PIM use was very high among the study population. This study assured the need for close monitoring of patients under polypharmacy since it can lead to higher number of DRPs and increased hospital stay.

Key words: Polypharmacy, Geriatrics, Multiple Comorbidities, potentially inappropriate medications

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.